HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frédéric Baribaud Selected Research

CNTO3157

1/2018Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frédéric Baribaud Research Topics

Disease

8Asthma (Bronchial Asthma)
01/2022 - 06/2015
7Inflammation (Inflammations)
01/2019 - 02/2012
6Infections
11/2007 - 04/2002
4Ulcerative Colitis
10/2018 - 07/2011
3Psoriatic Arthritis
08/2022 - 01/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019 - 01/2017
3Ebola Hemorrhagic Fever
01/2003 - 08/2002
2Rheumatoid Arthritis
03/2020 - 01/2014
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Atopic Dermatitis (Atopic Eczema)
12/2020
1Reactive Arthritis (Reiter Disease)
03/2020
1Respiratory Tract Diseases (Respiratory Tract Disease)
06/2017
1Eosinophilia
06/2017
1Crohn Disease (Crohn's Disease)
05/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2014
1Sarcoidosis (Schaumann Disease)
06/2012
1Chronic Obstructive Pulmonary Disease (COPD)
02/2012
1Simian Acquired Immunodeficiency Syndrome
04/2007
1Opportunistic Infections (Opportunistic Infection)
04/2007
1Zlotogora-Ogur syndrome
05/2004

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
08/2022 - 06/2017
5DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
11/2007 - 08/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017 - 02/2012
4Infliximab (Remicade)FDA Link
01/2014 - 07/2011
3Monoclonal AntibodiesIBA
08/2022 - 12/2020
3Glycoproteins (Glycoprotein)IBA
11/2007 - 09/2002
2guselkumabIBA
08/2022 - 08/2022
2CollagenIBA
08/2022 - 08/2022
2Interleukin-12 (IL 12)IBA
01/2021 - 06/2012
2Pharmaceutical PreparationsIBA
10/2018 - 06/2015
2Interleukin-13IBA
09/2017 - 12/2016
2Oncostatin MIBA
05/2017 - 01/2017
2Messenger RNA (mRNA)IBA
08/2012 - 07/2011
2LectinsIBA
11/2007 - 08/2002
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2022
1P-2 (P 2)IBA
01/2022
1InterferonsIBA
01/2021
1Ustekinumab (CNTO 1275)FDA Link
01/2021
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1golimumabFDA Link
10/2018
1Tumor Necrosis Factor InhibitorsIBA
10/2018
1Toll-Like Receptor 3IBA
01/2018
1Pattern Recognition ReceptorsIBA
01/2018
1CNTO3157IBA
01/2018
1PeriostinIBA
09/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2017
1Immunoglobulin E (IgE)IBA
06/2017
1CytokinesIBA
05/2017
1Interleukin-4 (Interleukin 4)IBA
12/2016
1Small Interfering RNA (siRNA)IBA
06/2015
1GlucocorticoidsIBA
06/2015
1Interleukin-23 (Interleukin 23)IBA
06/2012
1InterleukinsIBA
06/2012
1CD40 Ligand (CD40L)IBA
02/2012
1Acute-Phase Proteins (Acute-Phase Protein)IBA
02/2012
1Epidermal Growth Factor (EGF)IBA
02/2012
1Proteins (Proteins, Gene)FDA Link
02/2012
1Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2012
1Biological ProductsIBA
07/2011
1Intercellular Adhesion Molecule-3IBA
11/2007
1Mannose (D-Mannose)IBA
11/2007
1Viral RNAIBA
04/2007
1NectinsIBA
05/2004
1HIV ReceptorsIBA
04/2003
1C-Type Lectins (C-Type Lectin)IBA
01/2003
1CalciumIBA
04/2002
1CC ChemokinesIBA
04/2002

Therapy/Procedure

9Therapeutics
10/2018 - 08/2002